Home > News > Biophan Technologies Files 8-K Providing NASA Conference Call Transcript
August 24th, 2004
Biophan Technologies Files 8-K Providing NASA Conference Call Transcript
Biophan Technologies, Inc. announced today that it has filed an 8-K with the Securities and Exchange Commission providing a transcript of the Company's investor conference call on Thursday, August 19, during which Biophan CEO Michael Weiner detailed to investors and other interested parties information on the Biophan / NASA's Ames Research Center agreement calling for characterization and joint development of high-density, nano-engineered thermoelectric materials for use with implantable medical devices.
Nano Ruffles in Brain Matter: Freiburg researchers decipher the role of nanostructures around brain cells in central nervous system function October 31st, 2014
Gold nanoparticle chains confine light to the nanoscale October 31st, 2014
'Nanomotor lithography' answers call for affordable, simpler device manufacturing October 31st, 2014
Device invented at Johns Hopkins provides up-close look at cancer on the move: Microscopic view of metastasis could give insight about how to keep cancer in check October 31st, 2014